Patient Safety Alert 13: Pharmacy Compounding (PDF)
The AMC PSO recently held its first Medication Safety Task Force collaborative convening session in order to discuss current issues in compounding sterile preparations and patient safety.
Attendees engaged in active discussions surrounding the most current pharmacy matters related to government and regulatory affairs, compounding source considerations, and identifying the next steps and challenges for compounding pharmacies, pharmacists, and health care clinicians.
Read the full report
- The AMC PSO’s goal in sponsoring this meeting was to: Introduce pharmacy leaders in the AMC PSO to the values of convening sessions held under its auspices
More AMC PSO Content
Publications such as whitepapers and guidelines derived from the AMC PSO convenings.
Programmable Medical Equipment Risks and Interventions
The AMC PSO has identified a series of practices employed to address the factors that can contribute to risk associated with programmable medical devices.
Wrong Site Surgery Report
The AMC PSO has identified the a series of practices employed to address the factors that can contribute to a wrong-site surgery.
The Risks of Programmable Medical Equipment
The AMC PSO has identified a broad array of programmable medical devices and made several recommendations to decrease risk due to user fallibility, equipment complexity, and highly variable processes.
PCA Pump Alarm Safety Concerns
The AMC PSO has identified a series of practices employed to address the factors that can contribute to risk associated with ambulatory pumps.
The Safety of Inpatient Health Care
Funded by CRICO, The Safety of Inpatient Health Care study published in the New England Journal of Medicine on January 12, 2023 is an important follow up to the landmark Harvard Medical Practice Study (HMPS), published in 1991.
Cookies help us improve your website experience.